VTYX- Ventyx Biosciences, Inc.

Name: Ventyx Biosciences, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Ventyx Biosciences, Inc. (VTYX) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 25 sells. VTYX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Mohan Raju	2.37M	$18.32M	-
Other	Nuss John	489.5K	$3.78M	-
Other	Forman Mark S	6.0K	$6.2K	-
VP	Gonzales Roy	5.3K	$5.5K	-
Dir	White William Richard	0	-	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 25, 2023	Auster Martin85	Chief Financial Officer	Sale+OE	28,000	$38.04	$1,064,990.19	-15.1%	-4.4%	-88.7%
Apr 25, 2023	Nsv Partners III LP89	10% Owner	Sell	100,000	$38.54	$3,853,992.81	-0.3%	-4.4%	-88.7%
Apr 25, 2023	Subramaniam Somu89	Director, 10% Owner	Sell	100,000	$38.54	$3,853,992.81	-0.3%	-4.4%	-88.7%
Apr 17, 2023	Auster Martin85	Chief Financial Officer	Sale+OE	7,000	$33.00	$231,013.30	-12.8%	+5.4%	-85.9%
Apr 13, 2023	Subramaniam Somu89	Director, 10% Owner	Sell	100,000	$30.23	$3,022,665.32	-0.5%	+15.1%	-85.0%
Apr 13, 2023	Nsv Partners III LP89	10% Owner	Sell	100,000	$30.23	$3,022,665.32	-0.5%	+15.1%	-85.0%
Apr 10, 2023	Mohan Raju83	Chief Executive Officer	Sell	9,255	$29.01	$268,519.02	-0.6%	+29.7%	-82.4%
Apr 6, 2023	Mohan Raju83	Chief Executive Officer	Sell	20,745	$29.52	$612,401.39	-0.4%	+32.3%	-83.1%
Apr 4, 2023	Auster Martin85	Chief Financial Officer	Sale+OE	21,000	$30.76	$646,034.65	-11.8%	+30.5%	-83.2%
Apr 3, 2023	Nuss John79	Chief Scientific Officer	Sale+OE	30,000	$32.87	$986,232.79	-5.8%	+23.2%	-84.0%

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC